Unique ER PR expression pattern in breast cancers with CHEK2 mutation: a hormone receptor and HER2 analysis based on germline cancer predisposition genes

被引:0
作者
Grace Wei
Mingxiang Teng
Marilin Rosa
Xia Wang
机构
[1] University of South Florida Morsani College of Medicine,Department of Biostatistics and Bioinformatics
[2] H. Lee Moffitt Cancer Center and Research Institute,Department of Pathology
[3] H. Lee Moffitt Cancer Center and Research Institute,undefined
[4] GeneHome Hereditary Cancer Screening Clinic,undefined
[5] H. Lee Moffitt Cancer Center & Research Institute,undefined
来源
Breast Cancer Research | / 24卷
关键词
Breast cancer; Germline cancer predisposition gene; ER; PR; HER2; Hormone receptor expression; Tumorigenesis;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 51 条
[1]  
Lischka A(2020)Genome instability profiles predict disease outcome in a cohort of 4,003 patients with breast cancer Clin Cancer Res 26 4606-4615
[2]  
Doberstein N(2005)Estrogen receptor-positive, progesterone receptor-negative breast cancer: association with growth factor receptor expression and tamoxifen resistance J Natl Cancer Inst 97 1254-1261
[3]  
Freitag-Wolf S(2009)Aberrant luminal progenitors as the candidate target population for basal tumor development in BRCA1 mutation carriers Nat Med 15 907-913
[4]  
Kocak A(2014)Intrinsic subtypes from PAM50 gene expression assay in a population-based breast cancer cohort: differences by age, race, and tumor characteristics Cancer Epidemiol Biomarkers Prev 23 714-724
[5]  
Gemoll T(2014)Intrinsic subtypes from the PAM50 gene expression assay in a population-based breast cancer survivor cohort: prognostication of short- and long-term outcomes Cancer Epidemiol Biomarkers Prev 23 725-734
[6]  
Heselmeyer-Haddad K(2015)Progesterone exposure and breast cancer risk: understanding the biological roots JAMA Oncol 1 283-285
[7]  
Arpino G(2010)Progesterone induces adult mammary stem cell expansion Nature 465 803-807
[8]  
Weiss H(2015)Breast cancer after use of estrogen plus progestin and estrogen alone: analyses of data from 2 women's health initiative randomized clinical trials JAMA Oncol 1 296-305
[9]  
Lee AV(2012)Pathology of breast and ovarian cancers among BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA) Cancer Epidemiol Biomark Prevent 21 134-147
[10]  
Schiff R(undefined)undefined undefined undefined undefined-undefined